Adams, A. R., Nortey, P. A., Dortey, B. A., Asmah, R. H., & Wiredu, E. K. (2019). Cervical Human Papillomavirus Prevalence, Genotypes, and Associated Risk Factors among Female Sex Workers in Greater Accra, Ghana. Journal of Oncology, 2019.
Adler, D., Wallace, M., Bennie, T., Abar, B., Sadeghi, R., Meiring, T., Williamson, A.-L., & Bekker, L.-G. (2015). High risk human papillomavirus persistence among HIV-infected young women in South Africa. International Journal of Infectious Diseases, 33, 219-221.
Akarolo-Anthony, S. N., Al-Mujtaba, M., Famooto, A. O., Dareng, E. O., Olaniyan, O. B., Offiong, R., Wheeler, C. M., & Adebamowo, C. A. (2013). HIV associated high-risk HPV infection among Nigerian women. BMC infectious diseases, 13(1), 521.
Akarolo-Anthony, S. N., Dal Maso, L., Igbinoba, F., Mbulaiteye, S. M., Adebamowo, C. A. J. I. a., & cancer. (2014). Cancer burden among HIV-positive persons in Nigeria: preliminary findings from the Nigerian AIDS-cancer match study. 9(1), 1.
Arbyn, M., Castellsague, X., De Sanjose, S., Bruni, L., Saraiya, M., Bray, F., & Ferlay, J. (2011). Worldwide Burden of Cervical Cancer in 2008. Annals of oncology, 22(12), 2675-2686.
Arbyn, M., Sasieni, P., Meijer, C. J., Clavel, C., Koliopoulos, G., & Dillner, J. (2006). Clinical applications of HPV testing: a summary of meta-analyses. Vaccine, 24, S78-S89.
Awofala, A. A., & Ogundele, O. E. (2018). HIV epidemiology in Nigeria. Saudi Journal of Biological Sciences, 25(4), 697-703.
Awua, A., Sackey, S., Osei, Y., Asmah, R., & Wiredu, E. (2016). Prevalence of human papillomavirus genotypes among women with cervical cancer in Ghana. Infectious agents and cancer, 11(1), 1.
Burd, E. M. (2003). Human papillomavirus and cervical cancer. Clinical Microbiology Reviews, 16(1), 1-17.
[Record #1249 is using a reference type undefined in this output style.]
Chaturvedi, A. K. (2010). Beyond cervical cancer: burden of other HPV-related cancers among men and women. Journal of Adolescent Health, 46(4), S20-S26.
Clifford, G., Franceschi, S., Diaz, M., Munoz, N., & Villa, L. L. (2006). HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine, 24, S26-S34.
Clifford, G. M., Goncalves, M. A. G., Franceschi, S., HPV, & group, H. s. (2006). Human papillomavirus types among women infected with HIV: a meta-analysis. Aids, 20(18), 2337-2344.
Dames, D. N., Ragin, C., Griffith-Bowe, A., Gomez, P., & Butler, R. (2009). The prevalence of cervical cytology abnormalities and human papillomavirus in women infected with the human immunodeficiency virus. Infectious agents and cancer, 4(1), S8.
Denny, L., Adewole, I., Anorlu, R., Dreyer, G., Moodley, M., Smith, T., Snyman, L., Wiredu, E., Molijn, A., Quint, W., Ramakrishnan, G., & Schmidt, J. (2014). Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa. International journal of cancer, 134(6), 1389-1398. https://doi.org/10.1002/ijc.28425
Denny, L. A., Franceschi, S., de Sanjosé, S., Heard, I., Moscicki, A. B., & Palefsky, J. (2012). Human papillomavirus, human immunodeficiency virus and immunosuppression. Vaccine, 30, F168-F174.
Donkoh, E. (2015). Distribution of Genital Human Papillomaviruses and Associated Cervical Disease in Kumasi Kwame Nkrumah University of Science and Technology]. Kumasi.
Donkoh, E. T., Agyemang-Yeboah, F., Asmah, R. H., & Wiredu, E. K. (2019). Prevalence of cervical cancer and pre-cancerous lesions among unscreened Women in Kumasi, Ghana. Medicine, 98(13), e14600.
Doorbar, J., Quint, W., Banks, L., Bravo, I. G., Stoler, M., Broker, T. R., & Stanley, M. A. (2012). The biology and life-cycle of human papillomaviruses. Vaccine, 30, F55-F70.
FDA. (2014 ). Approval letter—GARDASIL 9. http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm426520.htmExternal
Fonn, S., Bloch, B., Mabina, M., Carpenter, S., Cronje, H., Maise, C., Bennun, M., Du Toit, G., De Jonge, E., & Manana, I. (2015). Prevalence of pre-cancerous lesions and cervical cancer in South Africa-a multicentre study. South African Medical Journal, 92(2), 148-156.
Franceschi, S., & Jaffe, H. (2007). Cervical cancer screening of women living with HIV infection: a must in the era of antiretroviral therapy. Clinical infectious diseases, 45(4), 510-513.
[Record #1176 is using a reference type undefined in this output style.]
Getinet, M., Gelaw, B., Sisay, A., Mahmoud, E. A., & Assefa, A. (2015). Prevalence and predictors of Pap smear cervical epithelial cell abnormality among HIV-positive and negative women attending gynecological examination in cervical cancer screening center at Debre Markos referral hospital, East Gojjam, Northwest Ethiopia. BMC clinical pathology, 15(1), 1.
Ghebre, R. G., Grover, S., Xu, M. J., Chuang, L. T., & Simonds, H. (2017). Cervical cancer control in HIV-infected women: past, present and future. Gynecologic oncology reports, 21, 101-108.
Handlogten, K. S., Molitor, R. J., Roeker, L. E., Narla, N. P., Bachman, M. J., Quayson, S., Owusu-Afriyie, O., Adjei, E., Ankobea, F., & Clayton, A. (2014). Cervical Cancer Screening in Ghana, West Africa: Prevalence of Abnormal Cytology and Challenges for Expanding Screening. International Journal of Gynecologic Pathology, 33(2), 197-202.
[Record #1139 is using a reference type undefined in this output style.]
Humans, I. W. G. o. t. E. o. C. R. t., Meeting, I. W. G. o. t. E. o. C. R. t. H., Organization, W. H., & Cancer, I. A. f. R. o. (2007). Human papillomaviruses (Vol. 90). World Health Organization.
Isaakidis, P., Pimple, S., Varghese, B., Khan, S., Mansoor, H., Ladomirska, J., Sharma, N., Silva, E. D., Metcalf, C., & Caluwaerts, S. (2013). HPV infection, cervical abnormalities, and cancer in HIV-infected women in Mumbai, India: 12-month follow-up. International journal of women's health.
Kayumba, P. (2014). Prevalence of Cervical Cytology Abnormalities Among HIV Infected Women At Rwanda Military Hospital: A Cross-Sectional Desriptive Study University of Nairobi]. Nairobi.
Khan, M. J., Castle, P. E., Lorincz, A. T., Wacholder, S., Sherman, M., Scott, D. R., Rush, B. B., Glass, A. G., & Schiffman, M. (2005). The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. Journal of the National Cancer Institute, 97(14), 1072-1079.
Koss, L. G., & Melamed, M. R. (2006). Koss' diagnostic cytology and its histopathologic bases (Vol. 1). Lippincott Williams & Wilkins.
Krings, A., Boateng, G., Dunyo, P., Amuah, J. E., Adams, R. A., Adunyame, L., Nkansah, D. O., Wormenor, C. M., Hansen, B. T., & Gedzah, I. (2019). Dynamics of genotype-specific HPV clearance and reinfection in rural Ghana may compromise HPV screening approaches. Papillomavirus Research, 7, 45-51.
Lehtovirta, P., Paavonen, J., & Heikinheimo, O. (2008). Risk factors, diagnosis and prognosis of cervical intraepithelial neoplasia among HIV-infected women. Int J STD AIDS, 19(1), 37-41.
Marie-Eve, R., Petros, I., Chutema, P., & Tony, R. (2009). Screening and treating cervical cancer in HIV-positive women in Cambodia. JAIDS Journal of Acquired Immune Deficiency Syndromes, 51(5), 644-646.
Massad, L. S., Xie, X., Burk, R. D., D'Souza, G., Darragh, T. M., Minkoff, H., Colie, C., Burian, P., Palefsky, J., & Atrio, J. (2016). Association of cervical precancer with human papillomavirus types other than 16 among HIV co-infected women. Am J Obstet Gynecol, 214(3), 354. e351-354. e356.
Mbulaiteye, S. M., Bhatia, K., Adebamowo, C., & Sasco, A. J. (2011). HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data. Infectious agents and cancer, 6(1), 16.
Mbulaiteye, S. M., Katabira, E. T., Wabinga, H., Parkin, D. M., Virgo, P., Ochai, R., Workneh, M., Coutinho, A., & Engels, E. A. (2006). Spectrum of cancers among HIV‐infected persons in Africa: the Uganda AIDS‐Cancer Registry Match Study. International journal of cancer, 118(4), 985-990.
Meloni, A., Pilia, R., Campagna, M., Usai, A., Masia, G., Caredda, V., & Coppola, R. C. (2014). Prevalence and molecular epidemiology of human papillomavirus infection in Italian women with cervical cytological abnormalities. Journal of public health research, 3(1).
Memiah, P., Mbuthia, W., Kiiru, G., Agbor, S., Odhiambo, F., Ojoo, S., & Biadgilign, S. (2012). Prevalence and risk factors associated with precancerous cervical cancer lesions among HIV-infected women in resource-limited settings. AIDS research and treatment, 2012.
Menon, S., Wusiman, A., Boily, M. C., Kariisa, M., Mabeya, H., Luchters, S., Forland, F., Rossi, R., Callens, S., & Vanden Broeck, D. (2016). Epidemiology of HPV genotypes among HIV positive women in Kenya: a systematic review and meta-analysis. PLoS One, 11(10), e0163965.
Minkoff, H., Zhong, Y., Burk, R. D., Palefsky, J. M., Xue, X., Watts, D. H., Levine, A. M., Wright, R. L., Colie, C., & D'Souza, G. (2010). Influence of Adherent and Effective Antiretroviral Therapy Use on Human Papillomavirus Infection and Squamous Intraepithelial Lesions in Human Immunodeficiency Virus—Positive Women. The Journal of Infectious Diseases, 201(5), 681-690.
Munoz, N., Bosch, F., de Sanjose, S., Herrero, R., Castellsague, X., Shah, K., Snijders, P., Meijer, C., & Group, I. A. f. R. o. C. M. C. C. S. (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. New England Journal of Medicine, 348, 518 - 527.
Muzyka, A., Tarkany, O., Novikov, A., Moskalenko, E., Vysotsky, A., & Volokh, V. (2007). GraphPad Prism. In (Version 5.00) GraphPad Software, Inc. www.grahpad.com
Obiri-Yeboah, D., Akakpo, P. K., Mutocheluh, M., Adjei-Danso, E., Allornuvor, G., Amoako-Sakyi, D., Adu-Sarkodie, Y., & Mayaud, P. (2017). Epidemiology of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL) among a cohort of HIV-infected and uninfected Ghanaian women. BMC cancer, 17(1), 688.
Odida, M., Sandin, S., Mirembe, F., Kleter, B., Quint, W., & Weiderpass, E. (2011). HPV types, HIV and invasive cervical carcinoma risk in Kampala, Uganda: a case-control study. Infectious agents and cancer, 6(1), 8.
Park, E. K., Cho, H., Lee, S. H., Lee, S. G., Lee, S. Y., Kim, K. H., Lee, C. H., Chung, J. S., & Kwak, I. S. (2014). Human papillomavirus prevalence and genotype distribution among HIV-infected women in Korea. Journal of Korean medical science, 29(1), 32-37.
Petrosky, E., Bocchini Jr, J. A., Hariri, S., Chesson, H., Curtis, C. R., Saraiya, M., Unger, E. R., & Markowitz, L. E. (2015). Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices. MMWR, 64, 300-304.
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., Garcia, F. A., Moriarty, A. T., Waxman, A. G., & Wilbur, D. C. (2012). American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA: a cancer journal for clinicians, 62(3), 147-172.
Sinayobye, J. d. A., Sklar, M., Hoover, D. R., Shi, Q., Dusingize, J. C., Cohen, M., Mutimura, E., Asiimwe-Kateera, B., Castle, P. E., & Strickler, H. (2014). Prevalence and risk factors for High-Risk Human Papillomavirus (hrHPV) infection among HIV-infected and Uninfected Rwandan women: implications for hrHPV-based screening in Rwanda. Infectious agents and cancer, 9(1), 40.
Soccio, J., Brown, M., Comino, E., & Friesen, E. (2015). Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility. Journal of advanced nursing, 71(12), 2858-2866.
Strickler, H. D., Burk, R. D., Fazzari, M., Anastos, K., Minkoff, H., Massad, L. S., Hall, C., Bacon, M., Levine, A. M., & Watts, D. H. (2005). Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus–positive women. Journal of the National Cancer Institute, 97(8), 577-586.
Tao, L., Han, L., Li, X., Gao, Q., Pan, L., Wu, L., Luo, Y., Wang, W., Zheng, Z., & Guo, X. (2014). Prevalence and risk factors for cervical neoplasia: a cervical cancer screening program in Beijing. BMC Public Health, 14, 1185. https://doi.org/10.1186/1471-2458-14-1185
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015). Global cancer statistics, 2012. CA: a cancer journal for clinicians, 65(2), 87-108.
Torre, L. A., Siegel, R. L., Ward, E. M., & Jemal, A. (2016). Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiology and Prevention Biomarkers, 25(1), 16-27.
Weldegebreal, F., & Worku, T. (2019). Precancerous Cervical Lesion Among HIV-Positive Women in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. Cancer Control, 26(1), 1073274819845872.
Whitham, H. K., Hawes, S. E., Chu, H., Oakes, J. M., Lifson, A. R., Kiviat, N. B., Sow, P. S., Gottlieb, G. S., Ba, S., & Sy, M. P. (2017). A comparison of the natural history of HPV infection and cervical abnormalities among HIV-positive and HIV-negative women in Senegal, Africa. J Cancer Epidemiology Prevention Biomarkers, 26(6), 886-894.
WHO/ICO. (2010). Human Papillomavirus and Related Cancers In the World [Summary Report 2010](WHO Information Center on HPV and Cervical Cancer (HPV Information Centre) Issue. H. I. Centre). www. who. int/ hpvcentre
Wright, T. C., Stoler, M. H., Behrens, C. M., Sharma, A., Sharma, K., & Apple, R. (2014). Interlaboratory variation in the performance of liquid‐based cytology: Insights from the ATHENA trial. International journal of cancer, 134(8), 1835-1843.
Yar, D. D., Salifu, S. P., Darko, S. N., Annan, A. A., Gyimah, A. A., Buabeng, K. O., & Owusu‐Dabo, E. (2015). Genotypic characterisation of human papillomavirus infections among persons living with HIV infection; a case–control study in Kumasi, Ghana. Tropical Medicine & International Health.
Yar, D. D., Salifu, S. P., Darko, S. N., Annan, A. A., Gyimah, A. A., Buabeng, K. O., & Owusu‐Dabo, E. (2016). Genotypic characterisation of human papillomavirus infections among persons living with HIV infection; a case–control study in Kumasi, Ghana. Tropical Medicine & International Health, 21(2), 275-282.
Zeier, M., Nachega, J., Van Der Merwe, F., Eshun-Wilson, I., Van Schalkwyk, M., La Grange, M., Mason, D., Louw, M., & Botha, M. (2012). Impact of timing of antiretroviral therapy initiation on survival of cervical squamous intraepithelial lesions: a cohort analysis from South Africa. Int J STD AIDS, 23(12), 890-896.